CJC-1295 (No DAC) + Ipamorelin + GHRP-2 (Blend)
What is CJC-1295 (No DAC) + Ipamorelin + GHRP-2 (Blend)?
CJC-1295 without Drug Affinity Complex (no DAC) is a synthetic analog of growth hormone–releasing hormone (GHRH) that stimulates the pituitary gland to naturally release growth hormone (GH). Unlike the DAC version, it has a much shorter half-life, producing a more physiologic and pulsatile GH release pattern. Ipamorelin is a selective growth hormone secretagogue (GHS) and ghrelin receptor agonist that increases GH secretion without significantly affecting cortisol or prolactin. GHRP-2 (Growth Hormone Releasing Peptide-2) is a potent hexapeptide GHS that targets the ghrelin receptor and triggers strong GH release. In research settings, combining these three peptides may enhance GH output through multiple complementary pathways.
Potential Benefits Shown in Studies
Possible benefits of CJC‑1295 (no DAC) + Ipamorelin + GHRP‑2 Blend:
- Synergistic GH Release
- Enhanced Muscle Growth & Recovery
- Improved Fat Metabolism
- Better Sleep & Well‑being:
- Minimized Hormonal Side Effects
- Preserved Natural Rhythm
Mechanisms of Action
CJC-1295 (no DAC) + Ipamorelin + GHRP-2 may work together by:
- CJC-1295 (no DAC): Binding to GHRH receptors in the pituitary to initiate short bursts of GH release in a natural pulse pattern
- Ipamorelin: Selectively activating ghrelin receptors to release GH without unwanted hormone spikes
- GHRP-2: Potently activating ghrelin receptors for a stronger GH response compared to GHRP-6
- Increasing circulating IGF-1 to support protein synthesis, collagen formation, and recovery processes
- Combining GHRH and ghrelin receptor activation to amplify both GH pulse frequency and amplitude
- Supporting tissue repair, fat metabolism, and muscle preservation in research models
CJC-1295 (No DAC)
CJC-1295 (without DAC) is a synthetic peptide designed to mimic Growth Hormone-Releasing Hormone (GHRH), stimulating the pituitary gland to naturally produce and release growth hormone (GH). Unlike the DAC version, CJC-1295 (No DAC) has a shorter half-life, making it better suited for more controlled and pulsatile GH release—closer to the body's natural rhythm.
View peptide
Ipamorelin
Ipamorelin is a selective growth hormone secretagogue (GHS) peptide that stimulates the body's natural production of growth hormone (GH). It works by mimicking ghrelin, the "hunger hormone," but without significantly increasing cortisol or other unwanted side effects seen with older GH peptides. It's commonly studied for its potential benefits in muscle growth, recovery, and anti-aging.
View peptide
Research Highlights
Muscle and Fat Enhancements
Research and user-oriented reviews highlight improved body composition, fat loss, muscle gain, and recovery through increased GH output.
Pulse Frequency & Amplitude Optimization
Protocols combining these peptides are commonly used to mimic natural GH rhythms, supporting consistent GH pulsatility.
Controlled GH Secretion Without Off‑Target Hormones
Ipamorelin specifically avoids triggering cortisol or prolactin, offering cleaner GH stimulation.
Mimics Natural, Pulsatile GH Secretion
CJC‑1295 without DAC is a short-acting analog of GHRH that reproduces the body’s natural growth hormone (GH) pulse patterns, with a half-life of around 30 minutes.
Precise Control Without Receptor Desensitization
Its short duration allows for frequent administration that avoids pituitary down-regulation—a key advantage for maintaining physiologic GH sensitivity.
Rapid GH Response & IGF‑1 Pathway Activation
Used in conjunction with GHRP peptides like Ipamorelin, CJC‑1295 (no DAC) can enhance GH pulse amplitude and stimulate downstream IGF‑1 signaling for anabolic effects.
Clinical Potential in Muscle Growth, Fat Metabolism & Aging
Clinical and preclinical studies have linked CJC‑1295 (general notes across versions) to increases in GH/IGF‑1, improvements in body composition, sleep, and anti-aging markers—though human data remains limited for No DAC specifically.
Selective GH Secretagogue (GHS‑R1a Agonist)
Ipamorelin binds specifically to the ghrelin receptors in the pituitary, inducing growth hormone (GH) release without significantly impacting cortisol, ACTH, or prolactin—offering a cleaner profile compared to other GHRPs.
Musculoskeletal Support & Bone Health
Animal studies indicate that Ipamorelin may counteract glucocorticoid-induced muscle catabolism and increase bone mineral content, particularly enhancing tibial growth and bone density in female rats.
Precise, Pulsatile GH Release
Ipamorelin closely mimics natural GH secretion patterns by delivering targeted pulses, which helps maintain physiological hormone balance and potentially improves metabolic responses.
Potential Anti-Aging & Recovery Applications
Due to its selectivity and minimal hormonal side effects, Ipamorelin is under investigation as a research tool for muscle recovery, anti-aging protocols, and metabolic studies.
Molecular Structure
CJC-1295 (No DAC)
Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser
C₁₅₂H₂₅₂N₄₄O₄₂
3367.88 g/mol
Ipamorelin
Aib-His-D-2-Nal-D-Phe-Lys-NH₂ (Aib = 2-aminoisobutyric acid, 2-Nal = 2-naphthylalanine)
C₃₈H₄₉N₉O₅
711.86 g/mol